{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:59:39Z","timestamp":1790783979402,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006513","name":"Duke Clinical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019361","name":"Belvoir Media Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.amjcard.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T02:44:55Z","timestamp":1532400295000},"page":"1330-1338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Meta-Analysis and Trial Sequential Analysis Comparing Percutaneous Ventricular Assist Devices Versus Intra-Aortic Balloon Pump During High-Risk Percutaneous Coronary Intervention or Cardiogenic Shock"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6774-5849","authenticated-orcid":false,"given":"Saul A.","family":"Rios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-052X","authenticated-orcid":false,"given":"Claudio A.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weinreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilman","family":"Olmedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Villablanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Alvarez","family":"Villela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Hirji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio A.","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich P.","family":"Jorde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.07.011_bib0001","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000590","article-title":"Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States","volume":"3","author":"Kolte","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0003","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0004","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/eurheartj\/ehp274","article-title":"Evaluating percutaneous support for cardiogenic shock: data shock and sticker shock","volume":"30","author":"Desai","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0006","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jcin.2014.07.030","article-title":"Percutaneous circulatory assist devices for high-risk coronary intervention","volume":"8","author":"Myat","year":"2015","journal-title":"JACC Cardiovasc Interventions"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009885.pub2","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","author":"Storebo","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0008","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1503\/cmaj.051484","article-title":"What is the best evidence for determining harms of medical treatment","volume":"174","author":"Vandenbroucke","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0009","article-title":"Systematic review of percutaneous assist devices versus intra-aortic balloon pump during high-risk PCI and cardiogenic shock: meta-analysis and Trial Sequential Analysis","author":"Rios","year":"2017","journal-title":"PROSPERO Int Prospect Regist Syst Rev"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0010","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0011","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0012","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0013","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial sequential analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0014","article-title":"Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease","volume":"104(14):1144-7","author":"Bravo","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011986.pub2","article-title":"Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease","author":"Bravo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cpt.536","article-title":"Comment on: \"Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews","volume":"102","author":"Castellini","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0017","series-title":"GRADEpro Guideline Development Tool [Software]","year":"2015"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0018","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0019","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ahj.2006.05.031","article-title":"A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock","volume":"152","author":"Burkhoff","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.amjcard.2013.09.008","article-title":"Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial)","volume":"113","author":"Dangas","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0021","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0022","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","article-title":"Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock","volume":"26","author":"Thiele","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0023","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study","volume":"126","author":"O'Neill","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0024","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.resuscitation.2012.10.001","article-title":"Percutaneous left ventricular assistance in post cardiac arrest shock: comparison of intra-aortic blood pump and IMPELLA Recover LP2.5","volume":"84","author":"Manzo-Silberman","year":"2013","journal-title":"Resuscitation"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jamainternmed.2014.7856","article-title":"Trends in the use of percutaneous ventricular assist devices: analysis of national inpatient sample data, 2007 through 2012","volume":"175","author":"Khera","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0026","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/eurheartj\/ehp292","article-title":"Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials","volume":"30","author":"Cheng","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0027","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/eurheartj\/ehx363","article-title":"Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials","volume":"38","author":"Thiele","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0028","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1097\/CCM.0b013e31821e89b5","article-title":"The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience","volume":"39","author":"Engstrom","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0029","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00392-011-0403-3","article-title":"Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock","volume":"101","author":"Prondzinsky","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjcard.2018.07.011_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183193","article-title":"Acquired von Willebrand syndrome in cardiogenic shock patients on mechanical circulatory microaxial pump support","volume":"12","author":"Flierl","year":"2017","journal-title":"PLoS One"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918314292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918314292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:04:13Z","timestamp":1762077853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918314292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0002914918314292"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.07.011","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis and Trial Sequential Analysis Comparing Percutaneous Ventricular Assist Devices Versus Intra-Aortic Balloon Pump During High-Risk Percutaneous Coronary Intervention or Cardiogenic Shock","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}